Skip to content
Telehealth Graded
State guide

Colorado's two answers on GLP-1s

Which Colorado benefit you hold decides the answer, and the two say opposite things. State employees got weight-loss coverage on May 1, 2026, with the grandfathering rules gone and one drug named on the larger plan. Health First Colorado, on the same subject, prints a one-line note saying a weight-loss request does not get approved — then spells out two other diagnoses that do.

Every source on this page was read first-hand in September 2026, and each one below carries the date printed on the document itself.

2
documents cited
10
sourced facts
2
primary sources

What changed, and what the document says

  1. Coverage starts

    Covered

    May 1, 2026, across the employee health plans.

    “Effective May 1, 2026, employee health plans will cover GLP-1s for weight loss.”

    The State of Colorado — published by the Department of Personnel & Administration, Division of Human Resources — Effective May 1, 2026

  2. One drug, on the bigger plan

    Conditions apply

    Cigna members get Zepbound. Anything else needs a medical reason it has to be something else.

    “As part of the Benefit 360 Program, members on the Cigna plan will have access to the GLP-1 Zepbound for weight-loss indications, unless there is a medical necessity for another drug. Members on the Kaiser Permanente plan will continue to go through Kaiser Permanente's pre-authorization process.”

    The State of Colorado — published by the Department of Personnel & Administration, Division of Human Resources — Effective May 1, 2026

  3. Grandfathering is over

    Covered

    The old rule that limited this to certain employees ended on the same day the coverage began.

    “No. The grandfathering provision terminated on May 1, 2026. All employees are covered for GLP-1s for weight loss.”

    The State of Colorado — published by the Department of Personnel & Administration, Division of Human Resources — Effective May 1, 2026

  4. Diabetes coverage is separate

    Covered

    None of this touches GLP-1s prescribed for anything other than weight loss.

    “No. This change only impacts GLP-1s for weight loss. Coverage for GLP-1s for conditions other than weight loss, such as diabetes, will continue.”

    The State of Colorado — published by the Department of Personnel & Administration, Division of Human Resources — Effective May 1, 2026

  5. Medicaid's answer, in a parenthesis

    Not covered

    Weight loss on its own is carved out of the route to every non-preferred product, and the drug list repeats the point in a footnote under its GLP-1 table.

    “All other non-preferred products may be approved for members with an FDA-labeled diagnosis (excluding labeled use solely for weight loss)”

    Colorado Department of Health Care Policy and Financing — Effective July 1, 2026

  6. What the preferred ones are for

    Context

    Diabetes. That is the whole qualifying condition for the products Health First Colorado puts on its preferred tier.

    “Preferred products may be approved for members with a diagnosis of type 2 diabetes.”

    Colorado Department of Health Care Policy and Financing — Effective July 1, 2026

  7. The Wegovy door on Medicaid

    Conditions apply

    Cardiovascular history, and an overweight threshold set lower than most states use.

    “Member has established cardiovascular disease (history of myocardial infarction, stroke, or symptomatic peripheral arterial disease) and either obesity or overweight”

    Colorado Department of Health Care Policy and Financing — Effective July 1, 2026

  8. The Zepbound door, and what it costs you first

    Not covered

    Half a year on a breathing machine before the drug is reachable, unless you cannot use one at all.

    “Member has failed a 6-month trial of continuous positive airway pressure (CPAP) or has a contraindication to the use of PAP therapy.”

    Colorado Department of Health Care Policy and Financing — Effective July 1, 2026

  9. Who has to be involved

    Conditions apply

    Four specialties are named, and a family physician is not among them.

    “The requested medication is being prescribed by or in consultation with a neurologist, pulmonologist, otolaryngologist, or other sleep medicine specialist”

    Colorado Department of Health Care Policy and Financing — Effective July 1, 2026

  10. Renewing on Medicaid

    Context

    A year at a time, and the re-evaluation has to happen face to face.

    “Prescriber attests that an in-person clinical re-evaluation of OSA from baseline has been performed by the treating practitioner AND”

    Colorado Department of Health Care Policy and Financing — Effective July 1, 2026

Telehealth in Colorado

Some providers pay us a commission when you sign up through our links, at no extra cost to you.

Which of these companies serve Colorado?

Of the 284 companies we grade, 28 publish a list of the states they are licensed in. We checked 250 more and found no such list on any page we read; 6 we have not checked either way.

22 of those lists name Colorado: Gala Health, Care Bare Rx, Vita Bella, TelePeptide, Levity, Wisp, WePeptideRx, Ways2Well, TeleClinic, Tyde Wellness, Willow, ZYP Medical, VevaRx, Trimi, Enhance MD, HumeCare+, Rx.com, Mojoon, Peak Wellness, Sprout Health, Allara Health, and MEDvidi. That is a licensure claim each company makes about itself, not something we checked with a state board.

A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.

Coverage decides what you pay before cash does. See how state Medicaid programs cover GLP-1s and what a prior-authorization denial turns on.

Sources

Each document below was fetched and read on the date shown beside it, which is the date printed on the document — not always the date in its web address. All of them were read in September 2026.

  • FAQs: GLP-1s for Weight Loss Coverage Change — The State of Colorado — published by the Department of Personnel & Administration, Division of Human Resources. the effective date printed in the document's first line — this FAQ prints no publication date, and none is supplied here: Effective May 1, 2026.
  • Preferred Drug List (PDL) — Colorado Department of Health Care Policy and Financing. the effective line on page one — the GLP-1 section inside it carries its own separate heading date of 4/1/2026: Effective July 1, 2026.

Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.